DUBLIN–(BUSINESS WIRE)–The “US Macular Edema Market and Competitive Landscape – 2018” report has been added to ResearchAndMarkets.com’s offering. US Macular Edema Market and Competitive Landscape – 2018 provides comprehensive insights into Macular Ed…
Author: Business Wire
Kedalion Therapeutics to Present at 2018 BIO Investor Forum
MENLO PARK, Calif.–(BUSINESS WIRE)–Kedalion Therapeutics to Present at BIO Investor Forum
Turn-Key Health Hosts AHIP Panel, October 16, 2018: Highlights CMS Expansion of Med Advantage Supplemental Benefits Coverage
PHILADELPHIA–(BUSINESS WIRE)–Turn-Key Health Hosts AHIP Panel, October 16, 2018: Highlights CMS Expansion of Med Advantage Supplemental Benefits Coverage
Keen Eye et Iris Pharma s’associent pour intégrer l’intelligence artificielle aux études ophtalmologiques
PARIS–(BUSINESS WIRE)–Keen Eye, entreprise française spécialisée en analyse d’images biomédicales pour le secteur des sciences de la vie, a annoncé aujourd’hui avoir conclu un accord de partenariat stratégique avec Iris Pharma, société de recherche s…
Keen Eye und Iris Pharma arbeiten zusammen, um künstliche Intelligenz für Studien der Augenheilkunde verfügbar zu machen
PARIS–(BUSINESS WIRE)–Keen Eye, ein französisches Technologieunternehmen, das auf Bildanalysen für die Life-Science-Branche spezialisiert ist, gab heute eine strategische Partnerschaft mit Iris Pharma bekannt, einem weltweit führenden Auftragsforschu…
Riassunto: Keen Eye e Iris Pharma collaborano per portare l’intelligenza artificiale negli studi in campo oculistico
PARIGI–(BUSINESS WIRE)–Keen Eye, società tecnologica francese specializzata nell’analisi delle immagini per l’industria nel settore delle scienze biologiche, ha oggi annunciato un accordo di collaborazione strategica con Iris Pharma, organizzazione d…
Samenvatting: Keen Eye en Iris Pharma werken samen om kunstmatige intelligentie in te voeren bij oftalmologische studies
PARIJS–(BUSINESS WIRE)–Keen Eye, een Frans technologiebedrijf gespecialiseerd in beeldanalyse voor de biowetenschappelijke industrie, kondigde vandaag een strategische partnerschapsovereenkomst aan met Iris Pharma, een wereldwijd toonaangevende contr…
Resumen: Keen Eye e Iris Pharma se unen para ofrecer inteligencia artificial a estudios oftalmológicos
PARÍS–(BUSINESS WIRE)–Keen Eye, una compañía tecnológica francesa especializada en análisis de imágenes para el sector de las ciencias de la vida, ha anunciado hoy un acuerdo de asociación estratégica con Iris Pharma, una organización de investigació…
Children in Milwaukee Receive Free Comprehensive Eye Exams and Prescription Glasses as Part of a School Health Event
MILWAUKEE–(BUSINESS WIRE)–Milwaukee-area children received free eye screenings and prescription glasses as part of a school eye health event.
Keen Eye and Iris Pharma Team up to Bring Artificial Intelligence in Ophthalmology Studies
PARIS–(BUSINESS WIRE)–#IrisPharma–Keen Eye and Iris Pharma team up to bring AI in the preclinical ophthalmic drug development to make assays faster, more reliable and more efficient.
Keen Eye and Iris Pharma Team up to Bring Artificial Intelligence in Ophthalmology Studies
PARIS–(BUSINESS WIRE)–#IrisPharma–Keen Eye and Iris Pharma team up to bring AI in the preclinical ophthalmic drug development to make assays faster, more reliable and more efficient.
STAAR Surgical Announces Strategic Alliance Agreement with Dr. Tobias Neuhann in Germany, A Model for Collaboration with Single Site Ophthalmology Clinics
MONROVIA, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced a multi-year Strategic Alliance Agreement with Dr…
STAAR Surgical Announces Strategic Alliance Agreement with Dr. Tobias Neuhann in Germany, A Model for Collaboration with Single Site Ophthalmology Clinics
MONROVIA, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced a multi-year Strategic Alliance Agreement with Dr…
Aerie Pharmaceuticals, Inc. Announces Drug Application for Regulatory Approval Accepted for Review in Europe
DURHAM, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucom…
Aerie Pharmaceuticals, Inc. Announces Drug Application for Regulatory Approval Accepted for Review in Europe
DURHAM, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucom…
Spectrum Pharmacy Products Salutes the Nation’s Pharmacists During American Pharmacists Month
NEW BRUNSWICK, N.J.–(BUSINESS WIRE)–#APhA–Spectrum Pharmacy Products Celebrates Pharmacists and the Important Health Services They Provide in Honor of American Pharmacists Month.
Spectrum Pharmacy Products Salutes the Nation’s Pharmacists During American Pharmacists Month
NEW BRUNSWICK, N.J.–(BUSINESS WIRE)–#APhA–Spectrum Pharmacy Products Celebrates Pharmacists and the Important Health Services They Provide in Honor of American Pharmacists Month.
Visioneering Technologies, Inc. Enters European Market
ATLANTA–(BUSINESS WIRE)–Visioneering Technologies, Inc. (ASX: VTI), an innovative US-based medical device company dedicated to developing advanced products that improve vision, today announced that Medilens Nordic AB has been named an Authorized Dist…
Dicerna Announces Late-Breaking Data from the PHYOX Phase 1 Clinical Trial of DCR-PHXC Will Be Presented at ASN Kidney Week 2018
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Dicerna announced that late-breaking data from the PHYOX Phase 1 trial of DCR-PHXC for the treatment of PH will be presented at ASN Kidney Week 2018.
Alpha Source Group Names Vionnta Rivers Chief Commercial Officer
MILWAUKEE–(BUSINESS WIRE)–Alpha Source Group has hired Vionnta Rivers as chief commercial officer.